Get started
Author

Christelle Butel

SIV infection in wild gorillas
2006 · Fran Van Heuverswyn, Yingying Li, et al. · Nature · 408
African origin of the malaria parasite Plasmodium vivax
2014 · Weimin Liu, Yingying Li, et al. · Nature Communications · 229
PDF
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
2022 · Houriiyah Tegally, James E. San, et al. · Science · 179
Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon
2007 · Fran Van Heuverswyn, Yingying Li, et al. · Virology · 174
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon
2020 · Alexandra Calmy, Tamara Tovar Sanchez, et al. · The Lancet HIV · 161
The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness
2006 · Harr F Njai, Youssef Gali, et al. · Retrovirology · 103
PDF
Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage
2003 · Laurence Vergne, Anke Bourgeois, et al. · Virology · 100
PDF
Survey of Ebola Viruses in Frugivorous and Insectivorous Bats in Guinea, Cameroon, and the Democratic Republic of the Congo, 2015–2017
2018 · Helene M. De Nys, Placide Mbala Kingebeni, et al. · Emerging infectious diseases · 89
Inaccurate Diagnosis of HIV-1 Group M and O Is a Key Challenge for Ongoing Universal Access to Antiretroviral Treatment and HIV Prevention in Cameroon
2009 · Avelin F. Aghokeng, Eitel Mpoudi-Ngole, et al. · PLoS ONE · 89
High rates of virological failure and drug resistance in perinatally HIV‐1‐infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo
2016 · Mounerou Salou, Anoumou Y Dagnra, et al. · Journal of the International AIDS Society · 87
PDF
Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions
2021 · Gytis Dudas, Samuel L. Hong, et al. · Nature Communications · 76
PDF
Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus
2016 · Ahidjo Ayouba, Abdoulaye Touré, et al. · Journal of Clinical Microbiology · 76
PDF
Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients
2011 · Avelin F. Aghokeng, Charles Kouanfack, et al. · AIDS · 72
Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantification and PCR amplification for drug resistance genotyping
2010 · M. Monleau, C. Butel, et al. · Journal of Antimicrobial Chemotherapy · 70
Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients
2006 · Laurence Vergne, Lieven Stuyver, et al. · Journal of Clinical Virology · 66
Virological failure rates and HIV‐1 drug resistance patterns in patients on first‐line antiretroviral treatment in semirural and rural Gabon
2012 · Florian Liégeois, Caroline Vella, et al. · Journal of the International AIDS Society · 63
PDF
HIV-1 Drug-Resistance Mutations among Newly Diagnosed Patients before Scaling-Up Programmes in Burkina Faso and Cameroon
2006 · Laurence Vergne, Serge Diagbouga, et al. · Antiviral Therapy · 59
PDF
No Difference in Clinical Progression between Patients Infected with the Predominant Human Immunodeficiency Virus Type 1 Circulating Recombinant Form (CRF) 02_AG Strain and Patients Not Infected with CRF02_AG, in Western and West‐Central Africa: A Four‐Year Prospective Multicenter Study
2002 · Christian Laurent, Anke Bourgeois, et al. · The Journal of Infectious Diseases · 56
Molecular Evidence for the Presence of Rickettsia Felis in the Feces of Wild-living African Apes
2013 · Alpha Kabinet Keita, Cristina Socolovschi, et al. · PLoS ONE · 52
PDF
Role of Wildlife in Emergence of Ebola Virus in Kaigbono (Likati), Democratic Republic of the Congo, 2017
2020 · Sophie Gryseels, Placide Mbala-Kingebeni, et al. · Emerging infectious diseases · 49
PDF
Prevalence of infection among asymptomatic and paucisymptomatic contact persons exposed to Ebola virus in Guinea: a retrospective, cross-sectional observational study
2019 · Mamadou Saliou Kalifa Diallo, Muriel Rabilloud, et al. · The Lancet Infectious Diseases · 48
PDF
Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon
2018 · Gaëlle F. Tchouwa, Sabrina Eymard-Duvernay, et al. · EClinicalMedicine · 44
PDF
Multiplex detection of antibodies to Chikungunya, O’nyong-nyong, Zika, Dengue, West Nile and Usutu viruses in diverse non-human primate species from Cameroon and the Democratic Republic of Congo
2021 · Raisa Raulino, Guillaume Thaurignac, et al. · PLoS neglected tropical diseases · 42
PDF
Identification of a New Circulating Recombinant Form of HIV Type 1, CRF11-cpx, Involving Subtypes A, G, J, and CRF01-AE, in Central Africa
2002 · Celine Montavon, Laurence Vergne, et al. · AIDS Research and Human Retroviruses · 42
Virological outcome and patterns of HIV‐1 drug resistance in patients with 36 months’ antiretroviral therapy experience in Cameroon
2013 · Avelin F Aghokeng, Charles Kouanfack, et al. · Journal of the International AIDS Society · 39
PDF
Works count: 80
Citation count: 3,104
H-index: 32
I10-index: 50
Year
Topic
Type